Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Idaho Gold and Antimony Project Retailers Add 22000 Jobs in April But Consumer Sentiment May Be Cooling Spencer Pratts Social Media Strategy Could Reshape Political Campaigning as He Eyes Los Angeles Mayors Office Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility Peloton Receives Price Target Upgrade from Goldman Sachs Amid Strong Subscription Trends Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer SREA Q1 2026 Earnings Earnings Per Share Slightly Misses Consensus Notes Edge Higher PBA Q1 2026 Earnings Earnings Beat Estimates on Strong Operational Execution AEMD Q1 2026 Earnings EPS Beats Estimates by 075 Amid Revenue Absence Stock Declines 1596 Gladstone Investment Corporation GAINN Q1 2026 Earnings EPS Misses Estimates by 88 as Investment Income Pressures Persist MRNA Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Sylvamo Corporation SLVM Q1 2026 Earnings A Wide Earnings Miss Amidst Market Headwinds BioAge Labs BIOA Slightly Declines as Biotech Sector Faces Mixed Sentiment JX Luxventure Group JXG Holds Steady Near Support as Market Awaits Catalyst First Community Corporation FCCO Hovers Near Support Amid Minimal Price Movement Magyar Bancorp Inc MGYR Edges Lower as Resistance Caps NearTerm Upside SunCoke Energy SXC Slips 096 as Resistance Holds Firm ING Develops AIPowered Trading System in Hours Capturing Wall Streets Attention REGCO Q1 2026 Earnings Preferred Stock EPS Beats Estimates Stock Edges Lower CDTTW Warrants Trade Flat at 001 Amidst Minimal Activity 3D Systems Q1 2026 Earnings NarrowerThanExpected Loss Amidst Strategic Shifts MSI Q1 2026 Earnings EPS Beat Expectations on Solid Operational Execution RAIL Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Inches Higher WFC Q1 2026 Earnings Narrow EPS Beat Lifts Shares as Revenue Picture Remains Unclear Nexa Resources Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline LTH Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares